Universe Pharmaceuticals (NASDAQ:UPC) Share Price Crosses Below 200-Day Moving Average – Should You Sell?

Shares of Universe Pharmaceuticals INC (NASDAQ:UPC) crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $3.88 and traded as low as $2.85. Universe Pharmaceuticals shares last traded at $2.88, with a volume of 188,197 shares trading hands.

Analysts Set New Price Targets

Several research analysts have recently weighed in on UPC shares. Wall Street Zen upgraded shares of Universe Pharmaceuticals to a “hold” rating in a research note on Saturday, August 29th. Weiss Ratings downgraded shares of Universe Pharmaceuticals from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, October 20th. One analyst has rated the stock with a Sell rating. According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Universe Pharmaceuticals Stock Down 13.8%

The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.90 and a current ratio of 4.05. The company has a 50 day moving average price of $4.37 and a 200 day moving average price of $3.85.

Universe Pharmaceuticals (NASDAQ:UPC) last posted its quarterly earnings results on Wednesday, July 29th. The company reported ($1.38) earnings per share for the quarter. The company had revenue of $4.52 million during the quarter.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals Inc is a pharmaceutical company focused on the development, manufacture, marketing and sale of products derived from traditional Chinese medicine. The company offers prescription and over-the-counter medicines, as well as certain health-related products, primarily for the Chinese market.

Its product portfolio is designed to address a range of therapeutic areas, including respiratory conditions, orthopedic disorders, cardiovascular and cerebrovascular diseases, and gynecological conditions.